7 / 7
Ear, Nose and Throat Disorders
Volume 8
Otolaryngology: Open Access
ENT Conference 2018
May 14-15, 2018
Page 25
Notes:
conference
series
.com
May 14-15, 2018 Osaka, Japan
2
nd
International Conference on
Effect of medical treatment on eradicatio of biofilms in CRS
C
hronic rhinosinusitis is one of the most common reasons for physician office visit, lost productivity in the work force and
antibiotic prescription. Recent researches on the pathogenesis of CRS have been focused on the potential role of biofilm
in the recalcitrant nature of disease. Anti-inflammatory therapies favorably topical steroids with low dose macrolides have
received an increasing interest in recent years. Studies have shown some influence on polyp size and patient symptoms also,
on biofilm formation in many steps. Our study group comprising of 48 patients, of which 24 were given macrolides along with
steroidal spray and rest 24, steroidal spray alone for 4 weeks underwent FESS surgery. We compared the pre-operative and post-
operative SNOT-20, endoscopic score, CT, scores and biofilm presence and density in both groups. Significant improvement
was seen in the SNOT-20 scores with p-value of 0.011 and endoscopic scores with p value of 0.001 in group having macrolides
along with steroids pre-operatively however the scores post-surgery didn’t show any such significant change in both groups.
The efficacy of macrolide with nasal steroidal spray or nasal spray alone showed no further benefit in the subjective outcome
measures post operatively. Also, no statistically significant eradication of biofilms or decrease in density could be appreciated
in both groups. Furthermore, there was no significant difference in recurrence rate. Our result demonstrated the subjective
improvement in patients of macrolide group post treatment which could be attributed to its anti-inflammatory effect. However,
the in ability of the macrolide group to represent any change in density of biofilm refutes many available studies. Even though
macrolides in combination with nasal spray reflected some improvement in the secondary outcomes but the primary outcome
of eradication of biofilms couldn’t be achieved. Hence, more research is needed to answer this topic and confirm the effectiveness
of clarithromycin on mucosal biofilms.
Biography
Lakshmi Vaid has completed her MBBS and MS (ENT) in 1982 from SMS Medical College, Jaipur, Rajasthan University. She is having work experience of more
than 35 years and at present, she is the Director, Professor and Head of ENT Dept. in University College of Medical Sciences and GTB Hospital, India. She has
published more than 45 papers in reputed journals.
Prof.vaid@gmail.comLakshmi Vaid
University College of Medical Sciences, India
Lakshmi Vaid, Otolaryngol (Sunnyvale) 2018, Volume 8
DOI: 10.4172/2161-119X-C1-024